BiotechTV - News

Jefferies London 2026: Valneva CEO Thomas Lingelbach shares an update on the status of the company's Lyme disease program (partnered with Pfizer) and more pipeline projects

Nov 17, 2026
Ask episode
Chapters
Transcript
Episode notes